A randomized, double-blind assessment of the sedative effects of intranasal dexmedetomidine during postoperative of surgical evacuation of the intracranial hemorrhage patients

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-15006668

Enrollment

Unknown

Registered

2015-06-30

Start date

2015-07-30

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intracranial hemorrhage

Interventions

D1 Group:nasal drops of DEX 1ug/kg

D2 Group:nasal drops of DEX1.5ug/kg

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Age 18-70; ASA I-IV

Exclusion criteria

Exclusion criteria: Coagulopathy; History of drug allergy; Hypertension; Liver and kidney dysfu; Taking sedatives 2d preoperative; Sinus bradycardia, preoperative emotions so nervous intolerance to local anesthesia of the patients.

Design outcomes

Primary

Measure	Time frame
BP;HR;SPO2;	—

Countries

China

Contacts

Public ContactLI JUAN

huamuzi1999@126.com+86 13956005465

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 2, 2026